Welltower (NYSE:WELL – Get Free Report) had its price objective raised by research analysts at Mizuho from $216.00 to $231.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm presently has an “outperform” rating on the real estate investment trust’s stock. Mizuho’s target price would suggest a potential upside of 12.58% from the company’s current price.
A number of other brokerages have also recently issued reports on WELL. Scotiabank upped their target price on Welltower from $214.00 to $236.00 and gave the stock a “sector outperform” rating in a report on Monday. Weiss Ratings cut Welltower from a “buy (b-)” rating to a “hold (c)” rating in a report on Tuesday, February 17th. UBS Group set a $240.00 price objective on Welltower in a research note on Thursday, February 12th. KeyCorp lifted their target price on shares of Welltower from $210.00 to $240.00 and gave the stock an “overweight” rating in a research report on Tuesday, February 24th. Finally, Morgan Stanley raised their price target on shares of Welltower from $200.00 to $215.00 and gave the company an “overweight” rating in a research note on Wednesday, February 18th. One research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $224.71.
Read Our Latest Report on Welltower
Welltower Trading Down 0.8%
Welltower (NYSE:WELL – Get Free Report) last released its quarterly earnings data on Tuesday, February 10th. The real estate investment trust reported $1.45 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.44 by $0.01. The business had revenue of $3.18 billion during the quarter, compared to analysts’ expectations of $2.93 billion. Welltower had a net margin of 8.64% and a return on equity of 2.46%. The firm’s quarterly revenue was up 41.3% compared to the same quarter last year. During the same period in the prior year, the company earned $1.13 EPS. Welltower has set its FY 2026 guidance at 6.090-6.25 EPS. Equities research analysts predict that Welltower will post 4.88 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Welltower
A number of hedge funds have recently bought and sold shares of WELL. Gunpowder Capital Management LLC dba Oliver Wealth Management bought a new position in shares of Welltower during the 4th quarter worth about $37,000. Rehmann Capital Advisory Group boosted its holdings in Welltower by 18.4% in the fourth quarter. Rehmann Capital Advisory Group now owns 4,112 shares of the real estate investment trust’s stock worth $763,000 after acquiring an additional 640 shares in the last quarter. Reflection Asset Management acquired a new stake in Welltower in the fourth quarter valued at approximately $155,000. Tempo Wealth LLC acquired a new stake in Welltower in the fourth quarter valued at approximately $374,000. Finally, Pacer Advisors Inc. increased its holdings in shares of Welltower by 10.0% during the fourth quarter. Pacer Advisors Inc. now owns 58,697 shares of the real estate investment trust’s stock valued at $10,895,000 after acquiring an additional 5,344 shares in the last quarter. Institutional investors own 94.80% of the company’s stock.
About Welltower
Welltower Inc (NYSE: WELL) is a real estate investment trust (REIT) that acquires and manages real estate serving the health care industry. The company specializes in healthcare infrastructure, owning and operating a diversified portfolio of senior housing, post-acute and long-term care communities, and outpatient medical properties. Welltower’s assets are designed to support the delivery of health care services through a combination of leased properties, joint ventures, and other capital arrangements with health care operators and providers.
The company’s property types include assisted living, memory care, independent living and skilled nursing facilities, as well as medical office buildings and other outpatient-care real estate such as ambulatory surgery centers and specialty clinics.
Featured Articles
- Five stocks we like better than Welltower
- Silver Is the New Oil—And the World’s Running Dry
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- What happened in Cyprus could be coming here
- Elon Musk’s $1 Quadrillion AI IPO
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Welltower Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Welltower and related companies with MarketBeat.com's FREE daily email newsletter.
